Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Total Current Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹944 Cr₹973 Cr₹683 Cr₹710 Cr₹526 Cr

What is the latest Total Current Liabilities ratio of NATCO PHARMA ?

The latest Total Current Liabilities ratio of NATCO PHARMA is ₹944 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹944 Cr
Mar2024₹973 Cr
Mar2023₹683 Cr
Mar2022₹710 Cr
Mar2021₹526 Cr

How is Total Current Liabilities of NATCO PHARMA Trending?

Years Total Current Liabilities % Change
Mar2025 ₹944 Cr
-3.01
Mar2024 ₹973 Cr
42.41
Mar2023 ₹683 Cr
-3.84
Mar2022 ₹710 Cr
35.16
Mar2021 ₹526 Cr -

Compare Total Current Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,700.5 Cr 10.7% 18.3% 21.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

10.7%

18.3%

21.8%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses